Liat Dassa
19Patents
3h-index
47Co-inventors
56Inventor score
Filing activity: Sep 3, 2008 → Aug 11, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9617336B2 | C10RF32 antibodies, and uses thereof for treatment of cancer | Physics | 11 | Active |
| US8415455B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 5 | Active |
| US9375466B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US9107862B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US10124061B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10227408B2 | Anti-PVRIG antibodies and methods of use | Physics | 2 | Active |
| US10751415B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US11623955B2 | Anti-PVRIG antibodies and methods of use | Physics | 1 | Active |
| US10550173B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 1 | Active |
| US10098934B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 1 | Active |
| US10213505B2 | Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9555087B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 1 | Active |
| US11220542B2 | Anti-PVRIG antibodies and methods of use | Physics | 1 | Active |
| US9714289B2 | Anti-PVRIG antibodies and methods of use | Physics | 1 | Active |
| US11795220B2 | Anti-PVRIG antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12312404B2 | Anti-PVRIG antibodies and methods of use | Physics | 0 | Active |
| US10351625B2 | Anti-PVRIG antibodies and methods of use | Physics | 0 | Active |
| US11701424B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11795209B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.